| Bilal Hameed, MD | |
|
194 Howard St Ste 1, New London, CT 06320-5544 | |
| (860) 440-0640 | |
| (860) 865-2397 |
| Full Name | Bilal Hameed |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 26 Years |
| Location | 194 Howard St Ste 1, New London, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063725190 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0008X | Psychiatry & Neurology - Neuromuscular Medicine | 62252 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lawrence & Memorial Hospital | New london, CT | Hospital |
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Westerly Hospital | Westerly, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation has today, during AF Association Global AF Aware Week, published a report that uncovers the growing burden of AF on patients, caregivers and healthcare systems across Europe.
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Uncovering the secrets of the brain requires an intense network of collaborative research. Building on a tool that was co-developed in his laboratory and described in a recent issue of Brain, Dr. Yaniv Assaf of Tel Aviv University's Department of Neurobiology is collaborating with an international team of scientists to understand how different parts of the human brain "connect" and to turn this information into a "brain atlas."
AstraZeneca today announced a two-year research collaboration with the University of Michigan to advance the treatment of chronic kidney disease (CKD) through the improved understanding of the disease. The collaboration will tackle the challenging area of identifying novel targets for the treatment of CKD, focusing on the use ofpatient tissue and validation of preclinical models.
Studying patients with kidney cancer, a team of researchers at Washington University School of Medicine in St. Louis has identified a pair of proteins excreted in the urine that could lead to earlier and more accurate diagnosis of the disease.
› Verified 3 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation has today, during AF Association Global AF Aware Week, published a report that uncovers the growing burden of AF on patients, caregivers and healthcare systems across Europe.
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Uncovering the secrets of the brain requires an intense network of collaborative research. Building on a tool that was co-developed in his laboratory and described in a recent issue of Brain, Dr. Yaniv Assaf of Tel Aviv University's Department of Neurobiology is collaborating with an international team of scientists to understand how different parts of the human brain "connect" and to turn this information into a "brain atlas."
AstraZeneca today announced a two-year research collaboration with the University of Michigan to advance the treatment of chronic kidney disease (CKD) through the improved understanding of the disease. The collaboration will tackle the challenging area of identifying novel targets for the treatment of CKD, focusing on the use ofpatient tissue and validation of preclinical models.
Studying patients with kidney cancer, a team of researchers at Washington University School of Medicine in St. Louis has identified a pair of proteins excreted in the urine that could lead to earlier and more accurate diagnosis of the disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bilal Hameed, MD 800 Howard Ave Lowr Level, New Haven, CT 06519-1369 Ph: (203) 785-7410 | Bilal Hameed, MD 194 Howard St Ste 1, New London, CT 06320-5544 Ph: (860) 440-0640 |
News Archive
Biosense Webster EMEA, a Division of Johnson & Johnson Medical NV/SA and leader in the treatment of Atrial Fibrillation has today, during AF Association Global AF Aware Week, published a report that uncovers the growing burden of AF on patients, caregivers and healthcare systems across Europe.
Using a patient's own bone marrow stem cells to treat acute stroke is feasible and safe, according to the results of a ground-breaking Phase I trial at The University of Texas Health Science Center at Houston.
Uncovering the secrets of the brain requires an intense network of collaborative research. Building on a tool that was co-developed in his laboratory and described in a recent issue of Brain, Dr. Yaniv Assaf of Tel Aviv University's Department of Neurobiology is collaborating with an international team of scientists to understand how different parts of the human brain "connect" and to turn this information into a "brain atlas."
AstraZeneca today announced a two-year research collaboration with the University of Michigan to advance the treatment of chronic kidney disease (CKD) through the improved understanding of the disease. The collaboration will tackle the challenging area of identifying novel targets for the treatment of CKD, focusing on the use ofpatient tissue and validation of preclinical models.
Studying patients with kidney cancer, a team of researchers at Washington University School of Medicine in St. Louis has identified a pair of proteins excreted in the urine that could lead to earlier and more accurate diagnosis of the disease.
› Verified 3 days ago
Dr. Sherrie Sharp, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 255 Hempstead St, New London, CT 06320 Phone: 860-443-2896 | |
Dr. Henry F Crabbe, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5 Shaws Cv Ste 207, New London, CT 06320 Phone: 860-444-8877 Fax: 860-444-9660 | |
Dr. Louis Henry Reich, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 292 Montauk Avenue, New London, CT 06320 Phone: 860-443-1200 Fax: 860-442-4488 | |
Dr. Stephen Glenn Vance, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 21 Montauk Ave, New London, CT 06320 Phone: 860-439-6400 Fax: 860-271-4797 | |
Dr. Ammar S Traboulsi, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 41 Fair Harbour Pl, New London, CT 06320 Phone: 860-437-6914 | |
Amy Stevens, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-271-4655 |